Logo

Chinese University of Hong Kong Licenses Fluidigm's BioMark RT-PCR System

May 28, 2007
NEW YORK (GenomeWeb News) - Fluidigm said last week that the Department of Chemical Pathology at the Chinese University of Hong Kong has licensed its BioMark real-time PCR system.
 
Fluidigm said that the lab is using the system to study viruses associated with cancer, to detect somatic mutations in genes, and to develop gene expression profiles, among other molecular diagnostic research projects.
 
Financial terms of the agreement were not provided.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.